Effects of different potassium-lowering regimens on acute hyperkalemia in hemodialysis patients: a real-world, retrospective study.
Lan YaoXiaoyang XingYubao LiFangxing ZhangPing LiXianhui LiangPei WangPublished in: Journal of translational medicine (2022)
Among MHD patients with acute hyperkalemia, SZC had similar potassium-lowering efficacy with IG intravenous administration at 2 h and superior on convenience and side-effects.